Bivalirudin: Anticoagulant Uses, Dosage, and Side Effects Guide

Summary of Key Points

Bivalirudin is an anticoagulant, commonly known as a blood thinner, used to prevent blood clots in patients with certain heart conditions or those undergoing specific medical procedures. It is frequently prescribed for acute coronary syndrome, unstable angina, and during coronary interventions. Bivalirudin works by inhibiting thrombin, an enzyme crucial for blood clot formation. Always consult your healthcare provider before making any changes to your medication regimen.

Names of Medication

US Brand Name: Angiomax (Bivalirudin)

The “generic name” refers to the active ingredient in a medication, which is not associated with a specific brand. In this case, Bivalirudin is the generic name.

Pharmacologic Category

Direct Thrombin Inhibitors

Anticoagulants

Bivalirudin Dosing

Bivalirudin is used to treat various conditions, and the dosage depends on the specific condition being managed. Always follow your healthcare provider’s instructions and consult them before adjusting your dose. You can also schedule a telemedicine appointment with one of our providers for further guidance.

Acute Coronary Syndrome (ACS): Initial dose of 0.1 mg/kg IV bolus, followed by 0.25 mg/kg/hour infusion.

Unstable Angina: 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion during the procedure.

Myocardial Infarction (Heart Attack): 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion.

Percutaneous Coronary Intervention (PCI): 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion during the procedure.

Thrombosis: 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion.

Deep Vein Thrombosis (DVT): 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion.

Pulmonary Embolism (PE): 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion.

Atrial Fibrillation: 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion.

Anticoagulation During Surgery: 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion during the procedure.

Coronary Artery Disease (CAD): 0.75 mg/kg IV bolus, followed by 1.75 mg/kg/hour infusion during the procedure.

Dosage Forms and Strengths

Injection: 250 mg lyophilized powder for reconstitution in a single-use vial

Administration Instructions for Bivalirudin

Bivalirudin is administered intravenously (IV), typically in a hospital or clinical setting by a healthcare professional. The dose is determined based on your weight and the condition being treated. If you are undergoing a procedure, the medication will be administered during the procedure. Always follow your healthcare provider’s instructions closely.

Bivalirudin Side Effects and Adverse Reactions

Like all medications, Bivalirudin can cause side effects. It is important to be aware of these and contact your healthcare provider if you experience any concerning symptoms.

Common Side Effects:

1. Bleeding: As a blood thinner, bleeding is the most common side effect, ranging from minor bruising to more serious bleeding.
2. Headache: Some patients may experience headaches while taking Bivalirudin.

Less Common Side Effects:

1. Low blood pressure (hypotension): This may occur during or after administration.
2. Back pain: Some patients report back pain after receiving Bivalirudin.

Serious Side Effects (Rare):

1. Severe bleeding: Seek medical attention immediately if you notice signs of serious bleeding, such as blood in your urine or stools, or if you are coughing up blood.
2. Allergic reactions: Symptoms may include rash, itching, swelling, or difficulty breathing. Contact your healthcare provider right away if you experience these symptoms.

Contraindications for Bivalirudin

A contraindication is a specific condition where a medication should not be used because it may be harmful. For Bivalirudin, there are several conditions where it is not recommended due to the increased risk of adverse effects.

Active major bleeding: As an anticoagulant, Bivalirudin thins the blood to prevent clotting. If you are already experiencing significant bleeding, taking Bivalirudin could worsen the situation and make it harder to control.

Severe uncontrolled hypertension (high blood pressure): High blood pressure increases the risk of bleeding, and Bivalirudin can further elevate this risk in patients with uncontrolled hypertension.

Hypersensitivity to Bivalirudin or its components: If you have had an allergic reaction to Bivalirudin or any of its ingredients, taking it again could cause a severe, potentially life-threatening allergic reaction.

Severe renal impairment: Bivalirudin is processed by the kidneys. If your kidneys are not functioning properly, the drug may not be cleared effectively, increasing the risk of bleeding or other side effects.

Drug-to-Drug Interactions with Bivalirudin

Certain medications can interact with Bivalirudin, increasing the risk of side effects or reducing its effectiveness. Inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Below are some medications that may interact with Bivalirudin:

Warfarin (Coumadin): Both Warfarin and Bivalirudin are anticoagulants. Taking them together can increase the risk of bleeding.

Aspirin (Bayer, Bufferin): Aspirin is a blood thinner, and when used with Bivalirudin, it can increase the risk of bleeding complications.

Clopidogrel (Plavix): Clopidogrel is an antiplatelet drug that prevents blood clots. Using it with Bivalirudin can raise the risk of bleeding.

Nonsteroidal anti-inflammatory drugs (NSAIDs) like Ibuprofen (Advil, Motrin): NSAIDs can increase the risk of gastrointestinal bleeding when taken with Bivalirudin.

Heparin: Heparin is another anticoagulant, and using it with Bivalirudin can increase the risk of bleeding.

Bivalirudin in Pregnancy

Is it safe to take Bivalirudin when pregnant?

There is limited information available regarding the use of Bivalirudin during pregnancy. While animal studies have not demonstrated harm to the fetus, no well-controlled studies have been conducted in pregnant women. Bivalirudin, an anticoagulant, should only be used during pregnancy if the potential benefits outweigh the risks. If you are pregnant or planning to become pregnant, it is essential to discuss the risks and benefits with your healthcare provider. You can also schedule a telemedicine consultation with one of our providers to discuss your specific situation in more detail.

Bivalirudin while Breastfeeding

Is it safe to take Bivalirudin while breastfeeding?

There is currently insufficient data to determine whether Bivalirudin passes into breast milk. Due to the potential for serious side effects in nursing infants, a decision should be made to either discontinue breastfeeding or stop the medication, depending on the importance of the drug to the mother. Consulting your healthcare provider is crucial to make an informed decision. You can also speak with one of our telemedicine providers to explore your options and receive personalized advice.

Estimated Cost of Bivalirudin Medication

The estimated cost of a 30-day supply of Bivalirudin without insurance, using a GoodRX coupon, typically ranges from $400 to $600. Prices may vary depending on the pharmacy and your location. Be sure to check with your local pharmacy and explore discount options to find the most affordable price for this anticoagulant medication.

Possible Alternatives to Bivalirudin

If Bivalirudin is not the right option for you, there are alternative treatments and lifestyle changes that may help manage your condition. Always consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to discuss these alternatives in more depth.

Alternatives for Specific Conditions

1. Acute coronary syndrome: Alternatives may include other anticoagulants such as Heparin or Enoxaparin (Lovenox). Lifestyle changes, including quitting smoking, following a heart-healthy diet, and engaging in regular exercise, can also help manage symptoms.
2. Unstable angina: Medications like Nitroglycerin, Beta-blockers, or Calcium channel blockers may be prescribed. Reducing stress and maintaining a healthy weight can further improve symptoms.
3. Myocardial infarction (heart attack): Thrombolytic therapy or other anticoagulants like Heparin may be used. Lifestyle changes, such as adopting a low-sodium diet and incorporating regular physical activity, can help prevent future heart attacks.
4. Percutaneous coronary intervention (PCI): Alternatives include other anticoagulants like Heparin or Enoxaparin. Discuss with your provider which option is most suitable for you.
5. Thrombosis: Warfarin or newer oral anticoagulants such as Apixaban (Eliquis) or Rivaroxaban (Xarelto) may be considered. Staying active and avoiding prolonged immobility can also help reduce the risk of blood clots.
6. Deep vein thrombosis (DVT): Alternatives include Warfarin, Apixaban, or Rivaroxaban. Compression stockings and regular movement, especially during long periods of sitting, can help prevent DVT.
7. Pulmonary embolism: Warfarin, Apixaban, or Rivaroxaban may be used. Staying active and maintaining a healthy weight can reduce the risk of future clots.
8. Atrial fibrillation: Alternatives include Warfarin, Apixaban, or Rivaroxaban. Managing high blood pressure and reducing alcohol intake can also help control symptoms.
9. Anticoagulation during surgery: Heparin or Enoxaparin may be used as alternatives. Your healthcare provider will determine the best option based on your specific surgical procedure.
10. Coronary artery disease: Medications such as Statins, Beta-blockers, or ACE inhibitors may be prescribed. Lifestyle changes, including a heart-healthy diet, regular exercise, and quitting smoking, are essential for managing coronary artery disease.

Recent Updates on Bivalirudin Research

Recent studies have compared Bivalirudin to other anticoagulants, such as Heparin, in patients undergoing percutaneous coronary interventions (PCI). Some research suggests that Bivalirudin may reduce the risk of major bleeding compared to Heparin, particularly in patients with acute coronary syndrome. However, other studies have indicated a slightly higher risk of stent thrombosis with Bivalirudin. Ongoing research is focused on optimizing Bivalirudin dosage and minimizing potential complications.

Staying informed about the latest research is important. Discuss any concerns with your healthcare provider, or schedule a telemedicine appointment with one of our providers to review your treatment plan and explore the most recent updates in Bivalirudin research.

James Kingsley

Learn More